Lassa fever vaccine
Latest Information Update: 23 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Lassa fever
Most Recent Events
- 16 Mar 2000 Preclinical development for Lassa fever in USA (PO)
- 16 Mar 2000 New profile